These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2703384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 3. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
    Kagiya VT, Nishimoto S, Ito T, Wang J, Abe M, Sasai K.
    Int J Radiat Oncol Biol Phys; 1992 Jul; 22(3):601-5. PubMed ID: 1735699
    [Abstract] [Full Text] [Related]

  • 4. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
    [Abstract] [Full Text] [Related]

  • 5. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 6. [Development of new hypoxic cell radiosensitizer in Japan].
    Mori T, Murayama C.
    Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
    [Abstract] [Full Text] [Related]

  • 7. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics.
    Sasai K, Iwai H, Yoshizawa T, Nishimoto S, Shibamoto Y, Oya N, Shibata T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):579-82. PubMed ID: 8005818
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H, Bando M, Hori H, Satoh T, Tada T, Onoyama Y, Inayama S.
    Int J Radiat Oncol Biol Phys; 1992 Jun 15; 22(3):561-4. PubMed ID: 1735696
    [Abstract] [Full Text] [Related]

  • 9. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T.
    Gan To Kagaku Ryoho; 1989 Apr 15; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [Abstract] [Full Text] [Related]

  • 10. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep 15; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 11. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M.
    Cancer Chemother Pharmacol; 1990 Sep 15; 26(2):112-6. PubMed ID: 2140730
    [Abstract] [Full Text] [Related]

  • 12. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
    Zhou L, Nishimoto S.
    Int J Radiat Biol; 1995 Mar 15; 67(3):335-46. PubMed ID: 7897282
    [Abstract] [Full Text] [Related]

  • 13. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1265-9. PubMed ID: 6236185
    [Abstract] [Full Text] [Related]

  • 14. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct 15; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 15. Clinical trials of radiosensitizers: what should we expect?
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Mar 15; 10(3):425-9. PubMed ID: 6231272
    [Abstract] [Full Text] [Related]

  • 16. Nitrotriazoles bearing sulfur-substituted side chains: preparation and characterization as hypoxic cell radiosensitizers.
    Sugita T, Masuoka M, Nishikawa Y, Nishimoto S, Zhou L, Sasai K, Kagiya T.
    Anticancer Drug Des; 1992 Jun 15; 7(3):277-84. PubMed ID: 1610484
    [Abstract] [Full Text] [Related]

  • 17. Azomycin riboside: a new radiosensitizer.
    Pedersen JE, Barron G, Chapman JD.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):415-8. PubMed ID: 7107360
    [Abstract] [Full Text] [Related]

  • 18. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo.
    Sugie C, Shibamoto Y, Ito M, Ogino H, Suzuki H, Uto Y, Nagasawa H, Hori H.
    J Radiat Res; 2005 Dec 15; 46(4):453-9. PubMed ID: 16394636
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM, Yu NY, Brown JM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1982 Dec 15; 8(3-4):435-8. PubMed ID: 7107364
    [Abstract] [Full Text] [Related]

  • 20. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ, de Ronde J, Hinchliffe M.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1281-5. PubMed ID: 6469751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.